View Cart  

Middle Eastern Countries Look to Decrease Pharmaceutical Imports

Eighty percent of drugs consumed in the Middle East are currently imported, but governments across the region are trying to change that by boosting domestic manufacturing and joint ventures and licensing deals, according to Frost & Sullivan’s analysis of the Gulf Cooperation Council (GCC) pharmaceutical market.

To View This Article:


Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00